| Before TDM | After TDM | p-Value * | |
| Antifungal therapy change | |||
| Switch to VRC Switch from VRC |
5 (41.7) 7 (58.3) |
8 (66.7) 4 (33.7) |
0.219 |
| Administration route | |||
| Parenteral Oral |
30 (96.8) 1 (3.2) |
31 (79.5) 8 (20.5) |
0.038 |
| Before TDM | After TDM | p-Value * | |
| Antifungal therapy change | |||
| Switch to VRC Switch from VRC |
5 (41.7) 7 (58.3) |
8 (66.7) 4 (33.7) |
0.219 |
| Administration route | |||
| Parenteral Oral |
30 (96.8) 1 (3.2) |
31 (79.5) 8 (20.5) |
0.038 |